GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.

GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.

UC Berkeley-aligned generalised robotics software developer Covariant, which emerged from stealth in January, has now assembled at least $67m of funding.

UC Berkeley-aligned generalised robotics software developer Covariant previously collected funding from Samsung Q Fund while it still operated in stealth mode.

Financial services provider Reyl and Cie has spun out Alpian in a bid to claim what it views as the market opportunity for a digital Swiss banking firm.

Tencent was among the investors in a $10m series A round for the digital health platform that was co-led by Global Ventures and Africa Healthcare Masterfund.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank Vision Fund and Sequoia Capital China have injected an additional $200m in funding to bring the series D round, already backed by the former, to $1.7bn.

Flint Hills Resources has contributed to a $133m series B round for RWDC Industries, which is working on a biodegradable alternative to plastic.

Novo Holdings has joined the early-stage consortium of Praxis Precision, a gene therapy business targeting neurological mechanisms across CNS-driven and psychiatric diseases.